Cover image of the article: In Silico Analysis of miRNA Role in Resistance of Hepatocellular Carcinoma Bel-7402 Cells to TRAIL

Image Credit:J Rep Pharm Sci

In Silico Analysis of miRNA Role in Resistance of Hepatocellular Carcinoma Bel-7402 Cells to TRAIL

Authors

Zohreh Salehi1, Homeyra Seydi1, Paria Hadadi1, Omid Tavallaei2,*
1Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
2Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
*Corresponding Author: Corresponding author: Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. Email:o.tavallaei@kums.ac.ir

Journal of Reports in Pharmaceutical Sciences:Vol. 9, issue 1; 11-8
Published online:Jun 26, 2020
Article type:Research Article
Received:Feb 21, 2019
Accepted:Dec 03, 2019
How to Cite:Salehi Z, Seydi H, Hadadi P, Tavallaei O. In Silico Analysis of miRNA Role in Resistance of Hepatocellular Carcinoma Bel-7402 Cells to TRAIL. J Rep Pharm Sci. 2020;9(1):e147275. doi: https://doi.org/10.4103/jrptps.JRPTPS_18_19

Abstract

Context: To this date, the exact basics of microRNAs (miRNAs) mechanisms in inducing a resistance to tumor necrosis factor –related apoptosis-inducing ligand (TRAIL) signaling pathways remain unclear. 
Aims: The aim of this study was to analyze miRNA signaling pathways in TRAIL-resistant Bel-7402 cell line.
Materials and Methods: The Gene Expression Omnibus (GEO) database was studied for miRNA expression profiling studies in TRAIL-resistant versus TRAIL-sensitive Bel-7402 cells. By searching through databases of DIANAmT, miRanda, miRDB, miRWalk, and PICTAR using the online tools of miRWalk and TargetScan, target genes of miRNAs were predicted to express differentially by up to 50% in TRAIL-resistant versus TRAIL-sensitive Bel-7402 cells. Afterwards, signaling pathways and biological functions of miRNA target genes in TRAIL-resistant versus TRAIL-sensitive Bel-7402 cells were analyzed by the DAVID database. 
Results: A total of 352 miRNAs (186 up- and 166 downregulated miRNAs) were obtained from GSE74130 GEO DataSets accession item. The upregulated miRNAs including hsamir- 145, hsa-mir-188, hsa-mir-221, hsa-mir-4802-5p, hsa-mir-198, hsa-mir-1184, and hsa-mir-345-3p were significantly intensified in apoptotic signaling pathway and process. The downregulated miRNAs including hsa-mir-138, hsa-mir-375, hsa-mir-449, hsa-mir-637, hsa-mir-208-3p, hsa-mir-4783-5p, hsamir- 548b-3p, hsa-mir-127-3p, hsa-mir-92b-5p, hsa-mir-375, hsa-mir-503-5p, hsa-mir-499a-3p, and hsamir- 154-3p were significantly raised in expression in cancer stem cell pathways. 
Conclusions: Analysis of miRNA expression profile revealed that some of the upregulated miRNAs negatively contributed to the regulation of apoptosis signaling pathways and cell cycle arrest as well as promoting TRAIL-induced apoptosis resistance in TRAIL-resistant Bel-7402 cells. Also, down-regulated miRNAs were probably involved in cancer stem cell processing. 
 

Highlights

Copyright

© 2020, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

1
Aug
2014
Role of MicroRNAs in Hepatocellular Carcinoma

Role of MicroRNAs in Hepatocellular Carcinoma

Zixiang Zhu,
Xiangle Zhang,
Guoqing Wang,
Haixue Zheng

Zhu Z, Zhang X, Wang G, Zheng H. Role of MicroRNAs in Hepatocellular Carcinoma. Hepat Mon. 2014;14(8):e18672. doi: https://doi.org/10.5812/hepatmon.18672

24
Nov
2019
Dysregulation of miR-638 in Breast Cancer Patients and Bioinformatics Investigation of Its Target Genes in Apoptosis, Angiogenesis and Autophagy Pathways

Dysregulation of miR-638 in Breast Cancer Patients and Bioinformatics Investigation of Its Target Genes in Apoptosis, Angiogenesis and Autophagy Pathways

Samaneh Ahmadi,
Mojtaba Saffari,
Mohammad Hossein Modarressi,
Reza Shirkoohi,
Marjan Jamalian,
Hossein Teimori

Ahmadi S, Saffari M, Modarressi MH, Shirkoohi R, Jamalian M, et al. Dysregulation of miR-638 in Breast Cancer Patients and Bioinformatics Investigation of Its Target Genes in Apoptosis, Angiogenesis and Autophagy Pathways. Int J Cancer Manag. 2019;12(11):e88829. doi: https://doi.org/10.5812/ijcm.88829

12
May
2024
MicroRNA-642a-5p Targets DNA Damage-Inducible Transcript 4 to Suppress Hepatitis B Virus Hepatoma Carcinoma Cell

MicroRNA-642a-5p Targets DNA Damage-Inducible Transcript 4 to Suppress Hepatitis B Virus Hepatoma Carcinoma Cell

Min Ding,
Juan Yang,
XueLi Zeng,
Pei Liu,
ShunLing Zhang,
Sheng Zheng

Ding M, Yang J, Zeng X, Liu P, Zhang S, et al. MicroRNA-642a-5p Targets DNA Damage-Inducible Transcript 4 to Suppress Hepatitis B Virus Hepatoma Carcinoma Cell. Jundishapur J Microbiol. 2024;17(3):e145798. doi: https://doi.org/10.5812/jjm-145798

23
Nov
2025
Oncogenic Function of miR-182-5p Versus Tumor-Suppressive Activities of miR-203, miR-150-5p, and miR-139-5p via Target Gene Regulation in Colon Cancer Metastasis

Oncogenic Function of miR-182-5p Versus Tumor-Suppressive Activities of miR-203, miR-150-5p, and miR-139-5p via Target Gene Regulation in Colon Cancer Metastasis

Sheryar Afzal,
Ali Attiq

Afzal S, Attiq A. Oncogenic Function of miR-182-5p Versus Tumor-Suppressive Activities of miR-203, miR-150-5p, and miR-139-5p via Target Gene Regulation in Colon Cancer Metastasis. Iran J Pharm Res. 2025;24(1):e164911. doi: https://doi.org/10.5812/ijpr-164911

24
Feb
2019
Plasma Level of miR-5193 as a Novel Biomarker for Diagnosis of HBV-Related Hepatocellular Carcinoma

Plasma Level of miR-5193 as a Novel Biomarker for Diagnosis of HBV-Related Hepatocellular Carcinoma

Niloofar Moradi,
Mahdi Paryan,
Behzad Khansarinejad,
Hossein Sarmadian,
Mahdieh Mondanizadeh

Moradi N, Paryan M, Khansarinejad B, Sarmadian H, Mondanizadeh M. Plasma Level of miR-5193 as a Novel Biomarker for Diagnosis of HBV-Related Hepatocellular Carcinoma. Hepat Mon. 2019;19(2):e84455. doi: https://doi.org/10.5812/hepatmon.84455

More by these authors

Zohreh SalehiPubMedScholar
Homeyra SeydiPubMedScholar
Paria HadadiPubMedScholar
Omid TavallaeiPubMedScholar
Share
Cited by
Metrics